Nasdaq Down 100 Points; Kala Pharmaceuticals Shares Spike Higher
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 100 points on Wednesday.
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal epithelial defect.
12 Health Care Stocks Moving In Wednesday’s Intraday Session
Gainers Kala Pharmaceuticals (NASDAQ:KALA) shares moved upwards by 314.3% to $16.24 during Wednesday’s regular session. Trading volume for…
Dow Tumbles 150 Points; Crude Oil Falls Sharply
U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 150 points on Wednesday.
US Stocks Rise; Dow Gains 100 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday.
What’s Going On With Kala Pharmaceuticals Stock?
Kala Pharmaceuticals Inc (NASDAQ: KALA) shares are trading higher Wednesday after the company announced FDA acceptance of an investigational new drug (IND) application for its KPI-012 for the
Cal-Maine Foods, Kala Pharmaceuticals And 3 Stocks To Watch Heading Into Wednesday
With US stock futures trading slightly higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers Kala Pharmaceuticals (NASDAQ:KALA) stock moved upwards by 68.1% to $6.59 during Tuesday’s after-market session. Kala Pharmaceuticals’s trading…
Kala Pharmaceuticals Announces FDA Acceptance Of IND Application For KPI-012 For The Treatment Of PCED; Received Remaining $25M Investment Under Previously Announced Private Placement Financing
On-track to initiate Phase 2b trial in 1Q 2023; Topline data expected in 1Q 2024 --
-- Received remaining $25 million investment under previously announced private placement financing --
